Mikael T. N.
- Country
- Norway
- Department
- Department of Opthalmology
Research Overview
Data & Insights
Has run more than one trial at 0 of 5 partner sites.
Specializations
Ocular & Vision Disorders
Focused on disorders that directly affect visual function and related sensory pathways.
- idiopathic sudden sensorineural hearing loss
- thyroid eye disease
- ocular oncology
Collaborates with Sørlandet sykehus Kristiansand to integrate ophthalmic expertise into multidisciplinary trials.
Oncology & Precision Medicine
Investigation of genotype‑guided therapies across a spectrum of solid and hematologic cancers.
- clear cell renal cancer
- KRAS G12C‑mutant non‑small cell lung cancer
- BRAF V600E‑mutant colorectal cancer
- ovarian cancer
- metastatic prostate cancer
Emphasizes molecular profiling to match patients with targeted agents.
Neurological & Neurodegenerative Disorders
Clinical evaluation of disease‑modifying and symptomatic treatments for nervous system disorders.
- amyotrophic lateral sclerosis
- multiple sclerosis
- glioblastoma
- idiopathic painful small fiber neuropathy
Includes strategies for pain relief and functional preservation.
Cardiovascular & Metabolic Diseases
Studies aimed at reducing morbidity and mortality from heart disease, stroke, and metabolic dysfunction.
- acute myocardial infarction
- atherosclerotic cardiovascular disease
- chronic heart failure
- type 2 diabetes
- hypertension
Targets secondary prevention and cardiovascular risk reduction.
Autoimmune & Inflammatory Conditions
Evaluation of immune‑modulating therapies for systemic autoimmune and inflammatory diseases.
- rheumatoid arthritis
- immune thrombocytopenia
- behçet’s syndrome
- juvenile idiopathic arthritis
- antiphospholipid syndrome
Incorporates therapeutic drug monitoring to optimize disease control.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.